Cancer Drug Current Events | Cancer Drug News | 6
|
| Page
6 of
140 |
2789 Results |
|
|
|
Sort By:
Page Views | Date |
Patient with rare disorder responds to cancer drug
A rare disorder caused by an excess of two types of immune cells-the mast cell found in various tissues and its blood-based twin, the basophil-has successfully been treated with a cancer drug, report scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). view more (2008-02-14)
Experimental Drug Boosts Survival in Recurrent Ovarian Cancer Patients
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently. view more (2007-09-28)
Genes set scene for metastasis
Biologists at Memorial Sloan-Kettering Cancer Center (MSKCC) have identified a set of genes expressed in human breast cancer cells that work together to remodel the network of blood vessels at the site of the primary tumor. view more (2007-04-12)
Humble yeast sheds light on promising anti-cancer drug
The humble yeast has revealed the molecular workings of an anti-cancer drug that stops the growth and spread of tumours in humans by starving their blood supply. view more (2005-10-19)
Further breakthroughs for breast cancer patients
Researchers at the Tenovus Centre for Cancer Research at Cardiff University have made a breakthrough in breast cancer treatment that could help save the lives of women who become resistant to breast cancer drugs such as tamoxifen. view more (2008-01-21)
Drug has ability to cure type of leukemia
In people with chronic myeloid leukemia (CML), the drug Imatinib has been shown to drive cancer into remission, but the disease often returns when treatment is stopped. view more (2007-10-03)
MRI drug may improve cancer-killing ability of chemotherapy, study says
A contrast agent currently used in magnetic resonance imaging (MRI), called mangafodipir, may increase the cancer-killing ability of some chemotherapy drugs while protecting normal cells. view more (2006-02-15)
Herbal Menopause Therapy a Good Fit for Breast Cancer Patients?
When it comes to understanding the effectiveness and safety of using herbal therapies with other drugs, much is unknown. Now, a University of Missouri researcher will study how black cohosh - an herbal supplement often used to relieve hot flashes in menopausal women - interacts with tamoxifen, a common drug used to treat breast cancer. view more (2008-10-08)
Jefferson scientists identify protein key to breast cancer spread, potential new drug target
Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread. view more (2007-04-10)
Trial Seeks 'Genetic Fingerprint' for Predicting Drug Effectiveness
University of Cincinnati (UC) physician-scientists believe identifying a genetic "fingerprint" could help predict which specific therapies will be most effective for patients with gastric cancer. view more (2007-10-04)
Chemotherapy with gemcitabine delays progression of operable pancreatic cancer
Giving pancreatic cancer patients the chemotherapy drug gemcitabine after surgery delays progression of the disease by about six months, according to new research by Japanese scientists. view more (2007-09-27)
Blocking Cancer-Causing Gene Improves Radiation Effectiveness, Jefferson Researchers Find
Inhibiting a particular cancer-causing gene can enhance the cell-killing effects of radiation, a team of radiation oncologists and cancer biologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found. view more (2006-11-09)
A longer lasting tumor blocker
On the heels of dismaying reports that a promising antitumor drug could, in theory, shorten patients' long-term survival, comes a promising study by a Japanese team of researchers that suggests a potentially better option. view more (2009-04-28)
Avoiding wishful thinking over new drugs - more trials should be double-blinded say cancer experts
Italian researchers have urged that doctors should, wherever possible, be 'blinded' to which drug a patient is receiving in a trial when the endpoint involves subjective judgements by the investigators. They believe it would lessen the risk of wishful thinking - an unconscious tendency by doctors to expect new drugs to perform better than the... view more... (2002-03-11)
Jefferson researchers uncover new evidence of prolactin's possible role in breast cancer
Scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have discovered new molecular evidence of the role of the hormone prolactin in breast cancer. view more (2007-10-01)
Study shows drug effective in treating, preventing breast cancer
A new study of an estrogen-derived drug shows promise as a treatment for breast cancer and breast cancer metastases to bone. view more (2007-11-01)
Prostate specific antigen: A review of PSA use in screening for prostate cancer
Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America. view more (2007-06-19)
Long-term tamoxifen use increases risk of an aggressive, hard to treat type of second breast cancer
While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than four-fold increased risk of a more aggressive, difficult-to-treat type of cancer in the breast opposite, or contralateral, to the initial tumor. view more (2009-08-26)
Scientists can now differentiate between healthy cells and cancer cells
One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. view more (2009-01-06)
Positive results more likely from industry-funded breast cancer trials
Industry-funded studies of breast cancer therapies are more likely to report positive results than non-pharmaceutical funded studies, researchers from the University of North Carolina at Chapel Hill and the Dana Farber Cancer Institute have found. view more (2007-02-26)
|
|
| Page
6 of
140 |
2789 Results |
|
|
|
Sort By:
Page Views | Date |
|
